News

heart drugs with stethoscope

The approval, made as part of a special FDA pilot program, took just 50 days.

Thumbnail

An interventional cardiologist believes he was targeted and terminated for being outspoken about a series of incidents at his hospital. 

broken relationship broken contract

The cardiovascular care of thousands of Missouri patients is suddenly up in the air. The heart of the issue is a practice's alleged interest in opening up a new private equity-backed clinic.  

Kathryn Berlacher, MD, MS, FACC, chair of the 2026 American College of Cardiology (ACC) 2026 Scientific Sessions, and clinical director of cardiology and a women's heart and cardio-obstetrics specialist at the University of Pittsburgh Medical Center, explains the major trend of artificial intelligence (AI) in cardiology, the use of coronary CT angiography (CCTA) for the first time at a medical meeting to scan attendees, and the rise in hands on, guideline, business and advocacy sessions.

ACC.26 Chair Kathryn Berlacher, MD, MS, explained some of the big trends at this year's meeting, including AI, CCTA, hands-on training and guideline sessions.

prescription drugs

Lower Medicare drug costs translated into more patients taking their medications, leading to better outcomes.

The SoloPace Fusion Temporary Pacing System from Solo Pace Inc. is deigned to eliminate the need for right ventricular (RV) lead placement, which requires the added procedural step to gaining venous access. This can cut procedure time and mitigate possible complication risks. For interventional cardiologists using improvised left ventricular (LV) pacing, this system can replace ad-hoc clip assemblies, subcutaneous needles and exposed wire connections, which are known sources of inconsistent pace capture.

New pacing system is designed to streamline TAVR cath lab workflows, cut procedural steps and increase reliability.

AI healthcare doctor surgery procedure artificial intelligence

Clinlab.AI will oversee every aspect of this new-look laboratory, working to integrate it with the practice's workflows in a way that boosts patient care and speeds up treatment decisions.

robot reviewing heart data

AI can help care teams identify heart patients who would benefit from TAVR or another life-changing valve intervention.

Seth Baum, MD, FACC, FACPM, FAHA, FNLA, FASPC, Chairman of the Board for the Family Heart Foundation, past president of the American Society for Preventive Cardiology, clinical affiliate professor of biomedical science at Florida Atlantic University, and chief medical officer of Flourish Research, explains why testing for familial hypercholesterolemia (FH) and elevated Lipoprotein(a) could be critical to identify more patients with elevated risk of cardiac events, but have their LDL well controlled.

"Lp(a) represents the most important potential potential paradigm shift in cardiovascular disease prevention that we'll experience over the next five to 10 years," Seth Baum, MD, explained in a new interview.

Conformal Medical CLAAS

New Hampshire-based Conformal Medical plans on using the funds to enroll more patients into an ongoing clinical trial. 

coronary sinus reducer shockwave medical

Treatment with the device is consistently safe, but researchers still think more data is required before reaching any conclusions about its efficacy. 

Video interview with Jaffar Khan, MD, St. Francis Heart Center, explaining tests using IVL in mitral annular calcification (MAC).

Jaffar Khan, MD, explained his team's work using intravascular lithotripsy balloons in a cadaver heart to break up mitral annular calcification. 

Around the web

The ramifications of the conflict in the Middle East may soon extend beyond the gas pump and into the healthcare sector, experts are cautioning.